Sitemap > Breaking Research > Cardiovascular Disorders
Displaying 101 - 150 of 4862 results
- Caspase-8 and caspase-3 small interfering RNA decreases ischemia/reperfusion injury to the liver in mice.
- Pilot assessment of the response of several pulmonary hemodynamic variables to sublingual sildenafil in candidates for heart transplantation.
- Outcomes and cost of deep venous thrombosis among patients with cancer.
- Repertaxin, a novel inhibitor of rat CXCR2 function, inhibits inflammatory responses that follow intestinal ischaemia and reperfusion injury.
- Treprostinil, a prostacyclin analogue, in pulmonary arterial hypertension associated with connective tissue disease.
- Acute coronary syndromes without chest pain, an underdiagnosed and undertreated high-risk group: insights from the Global Registry of Acute Coronary Events.
- Quality of life after coronary artery bypass graft: results from the POST CABG Trial.
- Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy.
- Low-dose therapy with the long-acting erythropoietin analogue darbepoetin alpha persistently activates endothelial Akt and attenuates progressive organ failure.
- Bradycardia induces angiogenesis, increases coronary reserve, and preserves function of the postinfarcted heart.
- Paclitaxel balloon coating, a novel method for prevention and therapy of restenosis.
- Impact of prolonged cyclooxygenase-2 inhibition on inflammatory markers and endothelial function in patients with ischemic heart disease and raised C-reactive protein: a randomized placebo-controlled study.
- Endothelial cells promote cardiac myocyte survival and spatial reorganization: implications for cardiac regeneration.
- A vascular cell-restricted RhoGAP, p73RhoGAP, is a key regulator of angiogenesis.
- Hypoxia-regulated therapeutic gene as a preemptive treatment strategy against ischemia/reperfusion tissue injury.
- Nifedipine retard was as effective as angiotensin converting enzyme inhibitors in preventing cardiac events in high-risk hypertensive patients with diabetes and coronary artery disease: the Japan Multicenter Investigation for Cardiovascular Diseases-B (JMIC-B) subgroup analysis.
- Effects of telmisartan compared with eprosartan on blood pressure control, glucose metabolism and lipid profile in hypertensive, type 2 diabetic patients: a randomized, double-blind, placebo-controlled 12-month study.
- Inhibition of endothelial cell proliferation by targeting Rac1 GTPase with small interference RNA in tumor cells.
- Characterization and comparative evaluation of a structurally unique PAI-1 inhibitor exhibiting oral in-vivo efficacy.
- Possible role of VEGF in the progression of kidney disease in streptozotocin (STZ)-induced diabetic rats: effects of an ACE inhibitor and an angiotensin II receptor antagonist.
- Oncolysis by viral replication and inhibition of angiogenesis by a replication-conditional herpes simplex virus that expresses mouse endostatin.
- Intracavernosal injection of vascular endothelial growth factor improves erectile function in aged rats.
- Inhibition of poly (ADP-ribose) polymerase and caspase-3, but not caspase-1, prevents apoptosis and improves spatial memory of rats with twice-repeated cerebral ischemia.
- Lung remodeling and pulmonary hypertension after myocardial infarction: pathogenic role of reduced caveolin expression.
- Granulocyte-macrophage colony-stimulating factor-induced arteriogenesis reduces energy failure in hemodynamic stroke.
- Functional properties of a recombinant chimeric plasminogen activator with platelet-targeted fibrinolytic and anticoagulant potential.
- Identification of a novel integrin alphavbeta3 binding site in CCN1 (CYR61) critical for pro-angiogenic activities in vascular endothelial cells.
- Coordinated series of studies to evaluate characteristics and mechanisms of acute coronary syndromes in high-risk patients randomly assigned to enoxaparin or unfractionated heparin: design and rationale of the SYNERGY Library.
- Association between different lipid-lowering treatment strategies and blood pressure control in the Brisighella Heart Study.
- Antecedent hypertension and the effect of captopril on the risk of adverse cardiovascular outcomes after acute myocardial infarction with left ventricular systolic dysfunction: Insights from the Survival and Ventricular Enlargement Trial.
- Does albuminuria predict cardiovascular outcome on treatment with losartan versus atenolol in hypertension with left ventricular hypertrophy? A LIFE substudy.
- Abeta is targeted to the vasculature in a mouse model of hereditary cerebral hemorrhage with amyloidosis.
- Statins but not fibrates are associated with a reduced risk of venous thromboembolism: a hospital-based case-control study.
- Single oral dose of geranylgeranylacetone for protection against delayed neuronal death induced by transient ischemia.
- Antagonists of stretch-activated ion channels restore contractile function in hamster dilated cardiomyopathy.
- In vitro selection of a peptide with high selectivity for cardiomyocytes in vivo.
- Inhibition of xenografted human melanoma growth and prevention of metastasis development by dual antiangiogenic/antitumor activities of pigment epithelium-derived factor.
- Pathophysiological effects of vascular endothelial growth factor receptor-2-blocking antibody plus fractionated radiotherapy on murine mammary tumors.
- Chronic inflammation and impaired coronary vasoreactivity in patients with coronary risk factors.
- Antiinflammatory effects of angiotensin II subtype 1 receptor blockade in hypertensive patients with microinflammation.
- Loss of collagen XVIII enhances neovascularization and vascular permeability in atherosclerosis.
- Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial.
- Alpha1-antitrypsin inhibits angiogenesis and tumor growth.
- Therapeutic levels of factor IX expression using a muscle-specific promoter and adeno-associated virus serotype 1 vector.
- Endothelial cell PECAM-1 confers protection against endotoxic shock.
- High-density lipoproteins retard the progression of atherosclerosis and favorably remodel lesions without suppressing indices of inflammation or oxidation.
- Inhibition of Rho-kinase leads to rapid activation of phosphatidylinositol 3-kinase/protein kinase Akt and cardiovascular protection.
- Evaluation of a novel in vitro Caco-2 hepatocyte hybrid system for predicting in vivo oral bioavailability.
- M40403 prevents myocardial injury induced by acute hyperglycaemia in perfused rat heart.
- Rapid regulation of P-glycoprotein at the blood-brain barrier by endothelin-1.
< Previous 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 | 56 | 57 | 58 | 59 | 60 | 61 | 62 | 63 | 64 | 65 | 66 | 67 | 68 | 69 | 70 | 71 | 72 | 73 | 74 | 75 | 76 | 77 | 78 | 79 | 80 | 81 | 82 | 83 | 84 | 85 | 86 | 87 | 88 | 89 | 90 | 91 | 92 | 93 | 94 | 95 | 96 | 97 | 98 Next >